abstract |
The invention relates to a-ketoamides of the general formula (see formula I) wherein R1 to R12 have the significances given in the description, and their salts, which are viral proteinase inhibitors useful as antiviral agents, especially for the treatment or prophylaxis of infections caused by hepatitis C, hepatitis G and human GB viruses. |